Recombinant secreted antigens from Mycoplasma hyopneumoniae delivered as a cocktail vaccine enhance the immune response of mice

Clinical and Vaccine Immunology

Volumn 20, Issue 9, 2013, Pages 1370-1376

  Galli, Vanessa ^a   Simionatto, Simone ^a,b   Marchioro, Silvana Beutinger ^a   Klabunde, Gustavo Henrique Ferrero ^a   Conceição, Fabricio Rochedo ^a   Dellagostin, Odir Antônio ^a  

^a FEDERAL UNIVERSITY OF PELOTAS   (Brazil)

^b UNIVERSIDADE FEDERAL DA GRANDE DOURADOS   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL VACCINE; BACTERIN; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN G1 ANTIBODY; IMMUNOGLOBULIN G2A ANTIBODY; LIPOPROTEIN; MHP0107 RECOMBINANT PROTEIN; MHP0272 RECOMBINANT PROTEIN; MHP0372 RECOMBINANT PROTEIN; MHP0418 RECOMBINANT PROTEIN; MHP0443 RECOMBINANT PROTEIN; MHP0487 RECOMBINANT PROTEIN; MHP0660 RECOMBINANT PROTEIN; RECOMBINANT PROTEIN; RECOMBINANT PROTEIN MHP0418 MHP0443 MHP0487 COCKTAIL VACCINE; RECOMBINANT PROTEIN MHP0418 MHP0660 MHP0372 COCKTAIL VACCINE; RECOMBINANT VACCINE; RESPISURE ONE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ARTICLE; CELL ADHESION; CELL LYSATE; CODON; CONTROLLED STUDY; DNA SEQUENCE; DRUG ANTIGENICITY; EXPERIMENTAL INFECTION; FEMALE; HUMORAL IMMUNITY; IMMUNOGENICITY; INOCULATION; MOUSE; MUTAGENESIS; MYCOPLASMAL PNEUMONIA OF SWINE; NONHUMAN; NUCLEOTIDE SEQUENCE; OPTICAL DENSITY; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BACTERIAL VACCINES; BLOTTING, WESTERN; ENZYME-LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; IMMUNOGLOBULIN G; MICE; MYCOPLASMA HYOPNEUMONIAE; PNEUMONIA OF SWINE, MYCOPLASMAL; RECOMBINANT PROTEINS; SWINE; VACCINATION; VACCINES, COMBINED; VACCINES, SYNTHETIC;

EID: 84884680777     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00140-13     Document Type: Article

References (35)

1. Thacker EL, Halbur PG, Ross RF, Thanawongnuwech R, Thacker BJ. 1999. Mycoplasma hyopneumoniae potentiation of porcine reproductive and respiratory syndrome virus-induced pneumonia. J. Clin. Microbiol. 37:620-627.
2. Ross RF. 1986. Mycoplasma disease, p 469-483. In Ross RF, Leman AD, Straw B, Glock RD, Mengeling WL, Penny RHC, Scholl E. Diseases of swine. The Iowa State University Press, Ames, IA.
3. Thacker EL, Thacker BJ, Kuhn M, Hawkins PA, Waters WR. 2000. Evaluation of local and systemic immune responses induced by intramuscular injection of a Mycoplasma hyopneumoniae bacterin to pigs. Am. J. Vet. Res. 61:1384-1389.
4. Meyns T, Dewulf J, De Kruif A, Calus D, Haesebrouck F, Maes D. 2006. Comparison of transmission of Mycoplasma hyopneumoniae in vaccinated and non-vaccinated populations. Vaccine 24:7081-7086.
5. Razin S, Yogev D, Naot Y. 1998. Molecular biology and pathogenicity of mycoplasmas. Microbiol. Mol. Biol. Rev. 62:1094-1156.
6. Vasconcelos AT, Ferreira HB, Bizarro CV, Bonatto SL, Carvalho MO, Pinto PM, Almeida DF, Almeida LG, Almeida R, Alves-Filho L, Assuncao EN, Azevedo VA, Bogo MR, Brigido MM, Brocchi M, Burity HA, Camargo AA, Camargo SS, Carepo MS, Carraro DM, Mattos Cascardo JC, Castro LA, Cavalcanti G, Chemale G, Collevatti RG, Cunha CW, Dallagiovanna B, Dambros BP, Dellagostin OA, Falcao C, Fantinatti-Garboggini F, Felipe MS, Fiorentin L, Franco GR, Freitas NS, Frias D, Grangeiro TB, Grisard EC, Guimaraes CT, Hungria M, Jardim SN, Krieger MA, Laurino JP, Lima LF, Lopes MI, Loreto EL, Madeira HM, Manfio GP, Maranhao AQ, Martinkovics CT, Medeiros SR, Moreira MA, Neiva M, Ramalho-Neto CE, Nicolas MF, Oliveira SC, Paixao RF, Pedrosa FO, Pena SD, Pereira M, Pereira-Ferrari L, Piffer I, Pinto LS, Potrich DP, Salim AC, Santos FR, Schmitt R, Schneider MP, Schrank A, Schrank IS, Schuck AF, Seuanez HN, Silva DW, Silva R, Silva SC, Soares CM, Souza KR, Souza RC, Staats CC, Steffens MB, Teixeira SM, Urmenyi TP, Vainstein MH, Zuccherato LW, Simpson AJ, Zaha A. 2005. Swine and poultry pathogens: the complete genome sequences of two strains of Mycoplasma hyopneumoniae and a strain of Mycoplasma synoviae. J. Bacteriol. 187:5568-5577.
7. Liu W, Feng Z, Fang L, Zhou Z, Li Q, Li S, Luo R, Wang L, Chen H, Shao G, Xiao S. 2011. Complete genome sequence of Mycoplasma hyopneumoniae strain 168. J. Bacteriol. 193:1016-1017.
8. Minion FC, Lefkowitz EJ, Madsen ML, Cleary BJ, Swartzell SM, Mahairas GG. 2004. The genome sequence of Mycoplasma hyopneumoniae Strain 232, the agent of swine mycoplasmosis. J. Bacteriol. 186:7123-7133.
9. Pinto PM, Klein CS, Zaha A, Ferreira HB. 2009. Comparative proteomic analysis of pathogenic and non-pathogenic strains from the swine pathogen Mycoplasma hyopneumoniae. Proteome Sci. 7:45.
10. Fagan PK, Walker M, Chiun J, Eamens GJ, Djordjevic SP. 2001. Oral immunization of swine with attenuated Salmonella Typhimurium aroA SL3261 expressing a recombinant antigen of Mycoplasma hyopneumoniae (NrdF) primes the immune system for a NrdF specific secretory IgA response in the lungs. Microb. Pathog. 30:101-110.
11. Chen YL, Wang SN, Yang WJ, Chen YJ, Lin HH, Shiuan D. 2003. Expression and immunogenicity of Mycoplasma hyopneumoniae heat shock protein antigen P42 by DNA vaccination. Infect. Immun. 71:1155-1160.
12. Shimoji Y, Oishi E, Muneta Y, Nosaka H, Mori Y. 2003. Vaccine efficacy of the attenuated Erysipelothrix rhusiopathiae YS-19 expressing a recombinant protein of Mycoplasma hyopneumoniae P97 adhesin against mycoplasmal pneumonia of swine. Vaccine 21:532-537.
13. Okamba FR, Arella M, Music N, Ji JJ, Gottschalk M, Gagnon CA. 2010. Potential use of a recombinant replication-defective adenovirus vector carrying the C-terminal portion of the P97 adhesin protein as a vaccine against Mycoplasma hyopneumoniae in swine. Vaccine 28:4802-4809
14. Chen AY, Fry SR, Daggard GE, Mukkur TK. 2008. Evaluation of immune response to recombinant potential protective antigens of Mycoplasma hyopneumoniae delivered as cocktail DNA and/or recombinant protein vaccines in mice. Vaccine 26:4372-4378.
15. Ramos CRR, Abreu PAE, Nascimento ALTO, Ho PL. 2004. A high-copy T7 Escherichia coli expression vector for the production of recombinant proteins with a minimal N-terminal His-tagged fusion peptide. Braz. J. Med. Biol. Res. 37:1103-1109.
16. Simionatto S, Marchioro SB, Galli V, Hartwig DD, Carlessi RM, Munari FM, Laurino JP, Conceição FR, Dellagostin OA. 2010. Cloning and purification of recombinant proteins of Mycoplasma hyopneumoniae expressed in Escherichia coli. Protein Expr. Purif. 69:132-136.
17. Simionatto S, Marchioro SB, Galli V, Luerce TD, Hartwig DD, Moreira AN, Dellagostin OA. 2009. Efficient site-direct mutagenesis using an overlap extension-PCR method for expressing Mycoplasma hyopneumoniae genes in Escherichia coli. J. Microbiol. Methods 79:101-105.
18. Simionatto S, Marchioro SB, Galli V, Brum CB, Klein CS, Rebelatto R, Silva EF, Borsuk S, Conceição FR, Dellagostin AO. 2012. Immunological characterization of Mycoplasma hyopneumoniae recombinant proteins. Comp. Immunol. Microbiol. Infect. Dis. 35:209-216.
19. Marchioro SB, Simionatto S, Galli V, Conceição FR, Brum CB, Fisch A, Gomes CK, Dellagostin AO. 2012. Production and characterization of recombinant transmembrane proteins from Mycoplasma hyopneumoniae. Vet. Microbiol. 155:44-52.
20. Zhang Q, Young TF, Ross RF. 1994. Glycolipid receptors for attachment of Mycoplasma hyopneumoniae to porcine respiratory ciliated cells. Infect. Immun. 62:4367-4373.
21. Zhang Q, Young TF, Ross RF. 1995. Identification and characterization of a Mycoplasma hyopneumoniae adhesion. Infect. Immun. 63: 1013-1019.
22. Hsu T, Minion C. 1998. Identification of the cilium binding epitope of the Mycoplasma hyopneumoniae P97 adhesin. Infect. Immun. 66:4762-4766.
23. Adams C, Pitzer J, Minion FC. 2005. In vivo expression analysis of the P97 and P102 paralog families of Mycoplasma hyopneumoniae. Infect. Immun. 73:7784-7787.
24. Pinto PM, Chemale G, De Castro LA, Metz AP, Kich J, Vainstein MH, Zaha A, Ferreira HB. 2007. Proteomic survey of the pathogenic Mycoplasma hyopneumoniae strain 7448 and identification of novel post-translationally modified and antigenic proteins. Vet. Microbiol. 121:83-93.
25. Behrens A, Heller M, Kirchhoff H, Yogev D, Rosengarten R. 1994. A family of phase-and size-variant membrane surface lipoprotein antigens (Vsps) of Mycoplasma bovis. Infect. Immun. 62:5075-5084.
26. Bhugra B, Voelker LR, Zou N, Yu H, Dybvig K. 1995. Mechanism of antigenic variation in Mycoplasma pulmonis: interwoven, site-specific DNA inversions. Mol. Microbiol. 18:703-714.
27. Djordjevic SP, Cordwell SJ, Djordjevic MA, Wilton J, Minion FC. 2004. Proteolytic processing of the Mycoplasma hyopneumoniae cilium adhesion. Infect. Immun. 72:2791-2802.
28. Mosmann TR, Coffman RI. 1989. Th1 and Th2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 7:145-173.
29. Liljeqvist S, Ståhl S. 1999. Production of recombinant subunit vaccines: protein immunogens, live delivery systems and nucleic acid vaccines. J. Biotechnol. 73:1-33.
30. Galli V, Simionatto S, Marchioro SB, Fisch A, Gomes CK, Conceição FR, Dellagostin AO. 2012. Immunisation of mice with Mycoplasma hyopneumoniae antigens P37, P42, P46 and P95 delivered as recombinant subunit or DNA vaccines. Vaccine 31:135-140.
31. Okamba FR, Moreau E, Cheikh Saad Bouh K, Gagnon CA, Massie B, Arella M. 2007. Immune responses induced by replication-defective adenovirus expressing the C-terminal portion of the Mycoplasma hyopneumoniae P97 adhesin. Clin. Vaccine Immunol. 14:767-774.
32. Fachado A, Rodriguez A, Angel SO, Pinto DC, Vila I, Acosta A, Amendoeira RR, Lannes-Vieira J. 2003. Protective effect of a naked DNA vaccine cocktail against lethal toxoplasmosis in mice. Vaccine 21:1327-1335.
33. Hooper JW, Custer DM, Thompson E. 2003. Four-gene-combination DNA vaccine protects mice against a lethal vaccinia virus challenge and elicits appropriate antibody responses in nonhuman primates. Virology 306:181-195.
34. Kaur T, Sobti RC, Kaur S. 2011. Cocktail of gp63 and Hsp70 induces protection against Leishmania donovani in BALB/c mice. Parasite Immunol. 33:95-103.
35. Djordjevic SP, Eamens GJ, Romalis LF, Nicholls PJ, Taylor V, Chin J. 1997. Serum and mucosal antibody responses and protection in pigs vaccinated against Mycoplasma hyopneumoniae with vaccines containing a denatured membrane antigen pool and adjuvant. Aust. Vet. J. 75:504-511.